Both in Diagnostics
Achieve Life Sciences vs Celldex Therapeutics
Over the past year ACHV returned +45.1% and CLDX returned +25.5%; their daily moves had a correlation of 0.28.
ACHV +45.1% CLDX +25.5%Growth of $1, one year, split-adjusted
| Metric | ACHV | CLDX |
|---|---|---|
| Price | $6.98 | $29.93 |
| Market cap | $719.7M | $2.35B |
| Today | +3.71% | +0.74% |
| 1 month | −0.7% | −3.5% |
| 6 months | +45.4% | −13.0% |
| Year to date | +40.4% | +10.2% |
| 1 year | +36.6% | +20.9% |
| Revenue growth (YoY) | — | −97.0% |
| Gross margin | — | 100.0% |
| Net margin | — | −334104.5% |
| P/E (TTM) | — | — |
| Price / sales | — | 14,875.9× |
| Net cash | $172.4M | $717.6M |
| Dividend yield | — | — |
| Volatility (60d) | 60.5% | 47.7% |
| Short % of float | 28.1% | 13.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).